project id: TCGA-LUSC; case submitter id: TCGA-58-A46K; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; age at index: 59; days to birth: -21867; days to death: 1045; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1949; year of death: 2010; age at diagnosis: 21867; ajcc pathologic m: M0; ajcc pathologic n: N2; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C34.3; last known disease status: not reported; morphology: 8083/3; primary diagnosis: Basaloid squamous cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower lobe, lung; synchronous malignancy: No; tissue or organ of origin: Lower lobe, lung; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: yes; alcohol history: Not Reported; cigarettes per day: 0.547945205479452; pack years smoked: 10.0; is ffpe: false; composition: Not Reported; days to collection: 1491; days to sample procurement: 0; initial weight: 90.0; portion submitter id: TCGA-58-A46K-01A-11; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 5.0; percent necrosis: 20.0; percent neutrophil infiltration: 2.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 50.0; percent tumor nuclei: 85.0;